Point of Care Ultrasound for the Detection of Esophageal Food Bolus
WellSpan Health · NCT06507670
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 30
- US sites recruiting
- 1
- Study start
- July 1, 2024
- Record last updated
- June 3, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
This will be a prospective, observational, case-control study of adult patients presenting to the WellSpan York Hospital Emergency Department (YHED) with signs and symptoms of esophageal food or foreign body impaction. Point of care ultrasound (POCUS) will then be performed by a trained emergency physician to collect ultrasound data, including the presence or absence of direct visualization food bolus/foreign body, as well as secondary markers of dilatation, such as maximal esophageal area. Investigators will also enroll an age/sex-matched control group of asymptomatic individuals to establish baseline esophageal measurements.
Patients will otherwise receive medical treatment per standard of care. Subsequent interventions will also be documented, including glucagon, carbonated beverages, and esophagogastroduodenoscopy (EGD). If patients remain in the ED and improve without need for EGD they will undergo repeat ultrasound. Chart review at 1 month will be performed to establish results of EGD including improvement, recurrence, or presence of pathologic abnormalities. The investigators aim to establish normal and abnormal parameters to aid in the diagnosis of esophageal food impactions to predict need for definitive EGD management.
Being studied: Point of care ultrasound
Conditions: Esophageal Foreign Body; Esophageal Obstruction
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Eligibility (CASES)
- Inclusion criteria:
- Age ≥18 years
- Signs and symptoms of esophageal food bolus or foreign body
- Exclusion criteria:
- Prior esophageal surgery
- History of head/neck cancer
- Incarcerated individuals
- Individuals unable to provide consent
- Clinical instability or airway compromise
Eligibility (CONTROLS)
- Inclusion criteria:
- Age ≥18 years
- NO signs or symptoms of esophageal food bolus or foreign body
- Age/Sex match to previously enrolled case subject
- Exclusion criteria:
- Prior esophageal surgery/dilation/pathology
- History of head/neck cancer
- Incarcerated individuals
- Individuals unable to provide consent
- Clinical instability or airway compromise
- Presentation involving any of the following symptoms:
- Nausea/vomiting
- Diarrhea
- Abdominal pain
- Chest pain
- Shortness of breath
- Dysphagia/odynophagia
- Cough
Recruiting US locations
WellSpan Health York Hospital
York, PA 17403
Site contact: Kristen Oliff · 717-851-5075 · koliff@wellspan.org
Study contacts (from the official record)
- Kristen Oliff · 717-851-5075 · koliff@wellspan.org
- Brent Becker, MD · 717-851-4819 · bbecker2@wellspan.org
Similar studies in Pennsylvania
All healthy volunteers studies in Pennsylvania →- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
Intralesional 5-Fluorouracil (5FU), Topical Calcipotriene Treatment for SCC
Melissa Pugliano-Mauro
- Location
- Pittsburgh, PA
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteersPhase 1/Phase 2
A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease
Novartis Pharmaceuticals
- Location
- Philadelphia, PA + 7 other US sites
- Eligibility basics
- Ages 12–55
- RecruitingHealthy volunteersPhase 1/Phase 2
Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older
Sanofi
- Location
- Philadelphia, PA + 49 other US sites
- Eligibility basics
- Ages 60+
- RecruitingHealthy volunteersPhase 1
A Research Study Looking at How Different Doses of Study Medicine (Inno8) Work in the Body of People With Haemophilia A
Novo Nordisk A/S
- Location
- Hershey, PA + 4 other US sites
- Eligibility basics
- Ages 18–64 · Men only